We suspect that J&J will continue to pursue acquisitions, but none as large as Guidant.
We think investors will look past third-quarter guidance, as the company has historically been overly conservative, and react favorably to the quarter.
We think it is unlikely that these changes will modify purchasing and demand characteristics of medical devices. Hospitals have traditionally had little leverage in reducing device costs.
We view this as a relatively uneventful quarter for Abbott.
This website focuses on proverbs in the Swedish, Danish and Norwegian languages, and some parts including the links below have not been translated to English. They are mainly FAQs, various information and webpages for improving the collection.
This website focuses on proverbs in the Swedish, Danish and Norwegian languages, and some parts including the links below have not been translated to English. They are mainly FAQs, various information and webpages for improving the collection.